Page last updated: 2024-09-03

astragaloside a and Anterior Circulation Transient Ischemic Attack

astragaloside a has been researched along with Anterior Circulation Transient Ischemic Attack in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kan, P; Wang, J; Xiang, L; Xu, N; Yang, P; Yao, X; Zhu, Y1
Deng, X; Fang, F; Li, H; Li, M; Ma, S1
Li, J; Lu, J; Wan, H; Yang, J; Zhang, Y; Zhu, Z1

Other Studies

3 other study(ies) available for astragaloside a and Anterior Circulation Transient Ischemic Attack

ArticleYear
Astragaloside IV reversed the autophagy and oxidative stress induced by the intestinal microbiota of AIS in mice.
    Journal of microbiology (Seoul, Korea), 2018, Volume: 56, Issue:11

    Topics: Animals; Antioxidants; Autophagy; Autophagy-Related Protein 12; Bacteria; Beclin-1; Brain; Disease Models, Animal; Fatty Acids; Feces; Gastrointestinal Microbiome; Genetic Vectors; Glutathione; Homocysteine; Ischemic Attack, Transient; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; NADPH Oxidase 2; NADPH Oxidase 4; Oxidative Stress; Reactive Oxygen Species; Saponins; Stroke; Superoxide Dismutase; Triterpenes

2018
Astragaloside IV attenuates cognitive impairments induced by transient cerebral ischemia and reperfusion in mice via anti-inflammatory mechanisms.
    Neuroscience letters, 2017, 02-03, Volume: 639

    Topics: Animals; Anti-Inflammatory Agents; Cognitive Dysfunction; Disease Models, Animal; Inflammation; Ischemic Attack, Transient; Male; Mice; Neuroprotective Agents; NF-kappa B; Reperfusion; Saponins; Toll-Like Receptor 4; Triterpenes

2017
Synergistic protective effect of astragaloside IV-tetramethylpyrazine against cerebral ischemic-reperfusion injury induced by transient focal ischemia.
    Journal of ethnopharmacology, 2012, Mar-06, Volume: 140, Issue:1

    Topics: Animals; Astragalus Plant; Cardiovascular Agents; Caspase 3; Disease Models, Animal; Drug Synergism; Glucose; Hippocampus; Ischemic Attack, Transient; Male; Malondialdehyde; Neuroprotective Agents; Nimodipine; Nitric Oxide Synthase Type II; Phytotherapy; Plant Extracts; Positron-Emission Tomography; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; RNA, Messenger; Saponins; Superoxide Dismutase; Triterpenes

2012